---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-109132"
form_type: "8-K"
ticker: "VSEE"
cik: "0001864531"
company_name: "VSEE HEALTH, INC."
filed_at: "2023-10-13T23:59:59+00:00"
generated_at: "2026-06-10T00:14:11.952051+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Digital Health Acquisition receives additional Nasdaq delisting notice for failing 400 total shareholders rule

## Summary
- On Oct 9, 2023, Nasdaq notified DHAC that it fails to meet the 400 total shareholders requirement under Listing Rule 5450(a)(2).
- This is an additional basis for delisting beyond the earlier MVLS non-compliance letter dated Sept 28, 2023.
- DHAC requested a hearing for Nov 30, 2023 to appeal the MVLS determination and applied to transfer to Nasdaq Capital Market.
- The company plans to also address the 400 shareholder deficiency at the upcoming hearing.

## SEC filing metadata
- accession: 0001104659-23-109132
- form_type: 8-K
- ticker: VSEE
- cik: 0001864531
- company_name: VSEE HEALTH, INC.
- filed_at: 2023-10-13T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1864531/000110465923109132/0001104659-23-109132-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1864531/000110465923109132/tm2327497d3_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-109132
- JSON: https://secwatch.observer/filing/0001104659-23-109132.json
- Plain text: https://secwatch.observer/filing/0001104659-23-109132.txt

## Key facts
- Listing & Compliance Notices
  VSEE HEALTH, INC. received a nasdaq delisting notice notice regarding market value.
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: market value
  source text: September 28, 2023 (the “September 28, 2023 Letter”) from Nasdaq that the Company’s Securities would be delisted from Nasdaq Global because it has not regained compliance with the Market Value of Listed Securities (“MVLS”) Standard. In connection with the September 29, 2023 Letter, on October 4, 2023, the Company requested a hearing before the Nasdaq hearings panel (the “Hearing”) to appeal the MVLS determination and applied to list its Securities on The Nasdaq Capital Market (“NasdaqCM”). The Hearing is scheduled to be held on November 30, 2023 at 12:00 PM Eastern Time. The Company plans to a
  evidence_url: https://www.sec.gov/Archives/edgar/data/1864531/000110465923109132/0001104659-23-109132-index.htm
- Listing & Compliance Notices
  VSEE HEALTH, INC. received a nasdaq delisting notice notice regarding other (rules 5450(a)(2)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Rules: 5450(a)(2)
  source text: October 9, 2023, Digital Health Acquisition Corp., a Delaware corporation (the “Company”), received an additional letter (the “Letter”) from the staff (the “Staff”) at The Nasdaq Global Market (“Nasdaq Global”) notifying the Company that its not meeting the 400 total shareholders requirement under the Nasdaq Listing Rule 5450(a)(2) serves as an additional basis for delisting the Company’s securities (including the Common Stock, Units and Warrants) (the “Securities”) from Nasdaq Global. As previously reported by the Company on its Current Form on 8-K filed on September 29, 2023, it received a l
  evidence_url: https://www.sec.gov/Archives/edgar/data/1864531/000110465923109132/0001104659-23-109132-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.